-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H5P1/Bw6LP2CzgEYEpED4h2WfPHzKS8jlwDtodITk2y7pfIeg1TaXHhkokbyvJtD I//zoBSAO+OIuK8deLGhOw== 0000891618-96-001574.txt : 19960808 0000891618-96-001574.hdr.sgml : 19960808 ACCESSION NUMBER: 0000891618-96-001574 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960807 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: CALYPTE BIOMEDICAL CORP CENTRAL INDEX KEY: 0000899426 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-04105 FILM NUMBER: 96604997 BUSINESS ADDRESS: STREET 1: 1440 FOURTH STREET CITY: BERKELEY STATE: CA ZIP: 94710 MAIL ADDRESS: STREET 1: 1265 HARBOR BAY PKWY CITY: ALAMEDA STATE: CA ZIP: 94502 424B3 1 SUPPLEMENT TO PROSPECTUS 1 Filed pursuant to Rule 424(c); File Number 333-4105 CALYPTE BIOMEDICAL CORPORATION SUPPLEMENT TO PROSPECTUS DATED JULY 26, 1996 On August 6, 1996, Calypte Biomedical Corporation received a product license and an establishment license from the FDA to manufacture and sell in interstate and foreign commerce the Company's urine-based HIV-1 screening test for use in professional laboratory settings. In addition, the Company is required to perform a Phase IV study of paired urine and blood samples from 100 HIV positive women using the Company's screening test and to submit the results of such study to the FDA. August 7, 1996 -----END PRIVACY-ENHANCED MESSAGE-----